no statement of use filed
on 13 Jul 2020
Last Applicant/ Owned by
150 SIGNET DRIVE
TORONTO, ONTARIO
CA
M9L1T9
Serial Number
86958426 filed on 30th Mar 2016
Registration Number
N/A
Correspondent Address
ROBERT A. ROWAN
Filing Basis
1. intent to use current
Disclaimer
"USA"
"USA" The mark consists of the word "APOPHARMA" with "USA" underneath and a swoosh design at the end. APO PHARMA USA Pharmaceutical preparations, namely, prescription drugs for the treatment of multiple myeloma by slowing the growth of cancer cells, prescription drugs for the treatment of multiple myeloma by stopping the growth of cancer cells, prescription drugs for palliative treatment of patRead More
Pharmaceutical preparations, namely, prescription drugs for the treatment of multiple myeloma by slowing the growth of cancer cells, prescription drugs for the treatment of multiple myeloma by stopping the growth of cancer cells, prescription drugs for palliative treatment of patients with multiple myeloma, and prescription drugs for use as an iron chelator for the treatment of patients with transfusion iron overload due to thalassemia syndromes, prescription drugs for the treatment of iron-associated neurodegenerative conditions, namely, Parkinson's disease and neurodegeneration with brain iron accumulation, in particular, pantothenate kinase-associated neurodegeneration
No 86958426
No Service/Collective Mark
No RAR-2148-145
No
No
No
No
No
No
No
No
26.17.09 -
Curved line(s), band(s) or bar(s)
The mark consists of the word "APOPHARMA" with "USA" underneath and a swoosh design at the end.
Status Date | Action Taken |
---|---|
13th Jul 2020 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
13th Jul 2020 | ABANDONMENT - NO USE STATEMENT FILED |
05th Nov 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
04th Nov 2019 | EXTENSION 5 GRANTED |
04th Nov 2019 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
31st Oct 2019 | EXTENSION 5 FILED |
31st Oct 2019 | TEAS EXTENSION RECEIVED |
19th Jun 2019 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
09th May 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
07th May 2019 | EXTENSION 4 FILED |